• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Saturday, September 30, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

New Alzheimer’s disease findings to be shared at international conference

Bioengineer by Bioengineer
December 5, 2016
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

WHAT: The conference will review the most important and promising developments in Alzheimer's disease research. It encourages the exchange of ideas and techniques used to tackle one of the 21st century's most intractable problems. The aim is to accelerate the development of effective Alzheimer's disease treatments.

USC scientists will be available for embargoed interviews prior to the conference when some 1,100 worldwide leaders in Alzheimer's disease research will congregate in San Diego for a three-day event at the 9th annual conference for Clinical Trials on Alzheimer's Disease (CTAD).

Paul Aisen, director of the USC Alzheimer's Therapeutic Research Institute (ATRI), founded CTAD in 2008 along with Jacques Touchon, Bruno Vellas and Mike Weiner. Attendance at the conference will nearly triple this year compared to its inaugural year.

More than 70 researchers at USC are devoted to reimagining the way Alzheimer's disease is studied, diagnosed, prevented, treated and — perhaps one day — cured. These are the topics six USC scientists will speak about at CTAD:

  • Phase 3 clinical trial that used Eli Lilly's drug solanezumab in people with mild dementia
  • The search for Alzheimer's disease biomarkers in people with Down syndrome: a genetically predisposed population
  • Stem cell use and regenerative therapeutics for Alzheimer's disease treatment
  • Phase 3 clinical trial that used the drug LMTM on people with mild Alzheimer's disease to inhibit the accumulation of tau proteins
  • Safety and efficacy of low-dose Ladostigil in patients with mild cognitive impairment
  • The APOE gene and low levels of amyloid beta protein 42 (Abeta42) in cerebrospinal fluid may influence the activity of omega-3 fatty acids, which enhance synaptic plasticity, learning and memory
  • Continued progress on Alzheimer's disease trial design
  • Using algorithms to automatically classify adverse effects in clinical studies of Alzheimer's disease
  • Using an interactive, open-source platform to monitor risk in Alzheimer's disease clinical trials

WHEN: Thursday, Dec. 8 — Saturday, Dec. 10

The presentation "EXPEDITION3: A phase 3 trial of solanezumab in mild dementia due to Alzheimer's disease" will take place from 6:15-7:45 p.m. PST on Thursday, Dec. 8 and will be streamed live at http://www.ctad-alzheimer.com/live-expedition-3-webcast.

WHERE: Marriott Marquis San Diego Marina
333 West Harbor Drive
San Diego, CA 92101

WHO:

  • Paul Aisen, director of the USC Alzheimer's Therapeutic Research Institute
  • Michael Rafii, clinical director of the USC Alzheimer's Therapeutic Research Institute
  • Lon Schneider, director of the USC California Alzheimer's Disease Center
  • Hussein Yassine, assistant professor of medicine at the Keck School of Medicine of USC
  • Gustavo Jimenez-Maggiora, director of informatics at the USC Alzheimer's Therapeutic Research Institute
  • Rema Raman, director of biostatistics at the USC Alzheimer's Therapeutic Research Institute

RSVP for PRESS PASS: Call (213) 300-1381 or email [email protected]

###

Media Contact

Zen Vuong
[email protected]
213-300-1381
@USC

http://www.usc.edu

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Irritible Bowel Syndrome

New study will examine irritable bowel syndrome as long COVID symptom

September 29, 2023
Kaylie Cullison

True progression or pseudoprogression in glioblastoma patients?

September 29, 2023

Neural activity associated with motor commands changes depending on context

September 29, 2023

ASTRO 2023 Session shines spotlight on physician burnout

September 29, 2023
Please login to join discussion

POPULAR NEWS

  • blank

    Microbe Computers

    59 shares
    Share 24 Tweet 15
  • A pioneering study from Politecnico di Milano sheds light on one of the still poorly understood aspects of cancer

    35 shares
    Share 14 Tweet 9
  • Fossil spines reveal deep sea’s past

    34 shares
    Share 14 Tweet 9
  • Scientists go ‘back to the future,’ create flies with ancient genes to study evolution

    75 shares
    Share 30 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New study will examine irritable bowel syndrome as long COVID symptom

True progression or pseudoprogression in glioblastoma patients?

Neural activity associated with motor commands changes depending on context

Subscribe to Blog via Email

Oops! It seems you have several subscriptions pending confirmation. You can confirm or unsubscribe some from the Subscriptions Manager before adding more.

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 56 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In